Amanda Wood, PhD, at the American Lake Division of the VA Puget Sound Health Care System was selected as the site-PI for an important study of pharmacogenetics testing for the treatment of Major Depressive Disorder. This multi-site, randomized trial funded by the VA Office of Research and Development will enroll 2,000 patients to study the impact of pharmacogenetics testing on treatment efficacy and the ability to avoid contraindicated medications.